Total Payments
$237,841
2024 Payments
$40,434
Companies
50
Transactions
1,162
Medicare Patients
4,483
Medicare Billing
$757,167
Payment Breakdown by Category
Other$148,760 (62.5%)
Consulting$39,079 (16.4%)
Travel$25,491 (10.7%)
Food & Beverage$24,405 (10.3%)
Education$106.12 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $148,760 | 72 | 62.5% |
| Consulting Fee | $39,079 | 22 | 16.4% |
| Travel and Lodging | $25,491 | 42 | 10.7% |
| Food and Beverage | $24,405 | 1,017 | 10.3% |
| Education | $106.12 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $71,316 | 111 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $46,533 | 94 | $0 (2024) |
| Novo Nordisk Inc | $37,747 | 31 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $34,147 | 77 | $0 (2018) |
| Lilly USA, LLC | $27,443 | 32 | $0 (2021) |
| BIOTRONIK INC. | $3,390 | 62 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $3,345 | 34 | $0 (2024) |
| Amgen Inc. | $1,812 | 108 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,750 | 111 | $0 (2023) |
| Boston Scientific Corporation | $1,591 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,434 | 65 | Novo Nordisk Inc ($37,565) |
| 2023 | $7,726 | 139 | AstraZeneca Pharmaceuticals LP ($2,590) |
| 2022 | $11,069 | 154 | AstraZeneca Pharmaceuticals LP ($7,052) |
| 2021 | $23,614 | 198 | AstraZeneca Pharmaceuticals LP ($12,110) |
| 2020 | $43,719 | 145 | AstraZeneca Pharmaceuticals LP ($24,109) |
| 2019 | $61,569 | 180 | Boehringer Ingelheim Pharmaceuticals, Inc. ($40,610) |
| 2018 | $23,642 | 133 | ARALEZ PHARMACEUTICALS US INC. ($10,303) |
| 2017 | $26,069 | 148 | Aralez Pharmaceuticals US Inc. ($23,844) |
All Payment Transactions
1,162 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.77 | General |
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,006.25 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $66.69 | General |
| 12/05/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $51.59 | General |
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $1,341.00 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,393.75 | General |
| 11/07/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $158.79 | General |
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $96.04 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,943.75 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $139.36 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $39.61 | General |
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $145.38 | General |
| Category: Cardiovascular Device | ||||||
| 10/25/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.40 | General |
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,006.25 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $78.41 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $49.58 | General |
| Category: Obesity | ||||||
| 10/19/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $66.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,040 | 1,522 | $435,899 | $136,530 |
| 2022 | 24 | 963 | 1,580 | $441,304 | $161,547 |
| 2021 | 25 | 1,154 | 2,033 | $615,361 | $218,149 |
| 2020 | 27 | 1,326 | 2,422 | $718,250 | $240,941 |
Total Patients
4,483
Total Services
7,557
Medicare Billing
$757,167
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 410 | $72,643 | $35,067 | 48.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $40,800 | $16,570 | 40.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 109 | 112 | $85,456 | $15,485 | 18.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 51 | 102 | $40,800 | $12,845 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 179 | $26,597 | $11,099 | 41.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 87 | 91 | $25,596 | $9,279 | 36.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 20 | 20 | $30,143 | $7,446 | 24.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 19 | 76 | $9,500 | $3,677 | 38.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 17 | 17 | $9,605 | $2,969 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,890 | $2,897 | 36.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 16 | 55 | $21,560 | $2,841 | 13.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 50 | 50 | $7,500 | $2,375 | 31.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 16 | 16 | $8,560 | $2,221 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,072 | $1,911 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 33 | $3,828 | $1,863 | 48.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 30 | 35 | $6,595 | $1,834 | 27.8% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 17 | 17 | $5,525 | $1,533 | 27.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 25 | 37 | $4,255 | $1,397 | 32.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 22 | 22 | $11,550 | $1,190 | 10.3% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 13 | 16 | $1,600 | $499.23 | 31.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 37 | 40 | $2,300 | $396.51 | 17.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $2,502 | $283.56 | 11.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 12 | 12 | $1,339 | $241.20 | 18.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $1,562 | $223.65 | 14.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 24 | 31 | $1,123 | $199.95 | 17.8% |
About Dr. Osler Jay Guzon, MD
Dr. Osler Jay Guzon, MD is a Internal Medicine healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285683888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Osler Jay Guzon, MD has received a total of $237,841 in payments from pharmaceutical and medical device companies, with $40,434 received in 2024. These payments were reported across 1,162 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($148,760).
As a Medicare-enrolled provider, Guzon has provided services to 4,483 Medicare beneficiaries, totaling 7,557 services with total Medicare billing of $757,167. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Saint Louis, MO
- Active Since 05/09/2006
- Last Updated 08/13/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285683888
Products in Payments
- JARDIANCE (Drug) $95,894
- FARXIGA (Drug) $45,275
- ZONTIVITY (Drug) $34,104
- Wegovy (Drug) $16,409
- Kerendia (Drug) $3,170
- XARELTO (Drug) $1,757
- Optimizer (Device) $1,212
- ENTRESTO (Drug) $1,148
- Repatha (Biological) $1,098
- ELIQUIS (Drug) $771.25
- BRILINTA (Drug) $719.37
- Corlanor (Drug) $672.67
- LifeVest (Device) $640.04
- Acticor 7 VR-T DX (Device) $609.64
- WATCHMAN Access System (Device) $597.80
- WATCHMAN (Device) $482.40
- VERQUVO (Drug) $455.23
- Barostim Neo System (Device) $428.43
- Ozempic (Drug) $401.85
- AMVIA EDGE (Device) $300.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Louis
Dr. John Lasala, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Mark Fesler, Md, MD
Internal Medicine — Payments: $700,896
Internal Medicine $700,896
Dr. Katie Schroeder, Md, MD
Internal Medicine — Payments: $659,683
Internal Medicine $659,683
Edward Charbek, Md, MD
Internal Medicine — Payments: $260,967
Internal Medicine $260,967
Dr. Michael Reschak, M.d, M.D
Internal Medicine — Payments: $245,910
Internal Medicine $245,910
Dr. George Ansstas, Md, MD
Internal Medicine — Payments: $233,767
Internal Medicine $233,767